GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jul 29, 2026
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $158.82 thousand as of July 30, 2026. Its market cap has increased by 95.08% in one year.
Market Cap
158.82K
Enterprise Value
2.15M
Revenue
97.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since March 19, 2014, GB Sciences's market cap has decreased from 2.53M to 158.82K, a decrease of -93.73%. That is a compound annual growth rate of -20.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 158.82K | -38.01% |
| Dec 31, 2025 | 256.20K | -84.27% |
| Dec 31, 2024 | 1.63M | -36.83% |
| Dec 29, 2023 | 2.58M | -61.28% |
| Dec 30, 2022 | 6.66M | 2.29% |
| Dec 31, 2021 | 6.51M | -44.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 286.35K |
| Sorrento Therapeutics | 217.49K |
| Ampio Pharmaceuticals | 207.88K |
| Carisma Therapeutics | 188.30K |
| Lipella Pharmaceuticals | 151.10K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| Nascent Biotech | 103.71K |